item management s discussion and analysis of financial condition and results of operations 
overview management s discussion and analysis provides information with respect to the results of operations of the company for the years ended december  and  and the combined results of operations of the company and the predecessor for the year ended december  on july   the company purchased all of the outstanding capital stock of the predecessor and certain other related assets from lilly 
for discussion and comparative purposes  the results of operations of the predecessor from january  to july  and of the company from july  to december  have been combined 
this management s discussion and analysis of financial condition and results of operation contains forward looking statements that involve risks and uncertainties 
the company s actual results may differ significantly from the results discussed in the forward looking statements due to many factors  including but not limited to those discussed in item  business  the effect of general economic conditions  the impact of competitive products and pricing  customer demand  product development  commercialization and technological difficulties  us and foreign regulatory requirements  the effects of accounting policies and financing requirements  and other such risks and factors 
year ended december  compared to year ended december  the company reported worldwide sales of million for the year ended december   an increase of million or from domestic sales of million increased million while international sales of million increased million from on a consolidated basis  equipment sales of million increased during the current year due primarily to increased demand for the company s family of lifepak products  primarily the lifepak unit 
worldwide service revenue of million increased and supplies revenue of million increased from  driven by disposable and accessory product sales 
the increase in domestic revenue during  when compared to  resulted from a increase in out of hospital equipment sales  due mainly to strong demand for lifepak products  and from a increase in service and supplies revenue supplies revenue increased 
domestic hospital equipment sales increased over in line with total hospital market growth estimates 
the increase in international revenue for reflected a strong demand for lifepak products 
during the year ended december  worldwide product orders totaled million  an increase of million or over the comparable prior year 
the increase in product orders resulted primarily from strong demand for the lifepak products  and solid performance in the international markets 
international and domestic orders increased and  respectively  from conversely  product backlog at december  was million  down million from december  reflecting a company wide focus initiated during early to improve timeliness of customer product deliveries which resulted in a reduction in cycle times which currently average less than days 
gross profit of million increased million or during when compared to as a percentage of sales  gross profit decreased from in the prior year to in  largely as a result of changes in product mix  mainly higher service and supplies revenue  as well as certain trade in programs established earlier in the year which resulted in higher product discounts 
r d expenditures during were million  a decrease of million or from as a percentage of sales  r d expenses decreased from in to during selling  general and administrative sg a expenses of million for increased million or from the increase resulted from costs incurred to further develop the company s direct sales and service operations in europe  as well as increased selling expense related to higher sales volume in the current year 
as a percentage of sales  sg a expenses decreased to during from during management consulting fees due to bain capital  inc totaled million during during the fourth quarter of  the management consulting agreement was terminated 
no management consulting fees were incurred during interest expense totaled million during  a decrease of million from the decrease resulted from lower interest expense attributable to a reduction of the company s outstanding debt and lower interest rates obtained in the refinancing of the company s credit facility during december as a result of the above factors  net income totaled million during  an increase of million or from the comparable year 
company year ended december  compared to combined year ended december  for the year ended december   the company reported net income of million  or per share pro forma  an increase of from earnings of million 
as discussed below  results include two nonrecurring charges a million consulting fee payable to bain capital  inc and a charge of million  net of tax  relating to the write off of certain loan fees 
net income for  excluding these two nonrecurring items  was million  or per share pro forma 
the company reported worldwide sales of million for  reflecting a decrease of million or from domestic sales for the year were million  down from  while international sales of million represented a increase from the reduction in domestic sales volume is not considered representative of domestic sales activity because domestic sales were positively impacted by a million reduction of the company s domestic order backlog 
during  domestic backlog levels increased from the beginning to the end of the year 
the company s domestic product orders in increased over the increase in product orders resulted from strong performance in both the out of hospital and hospital markets bolstered by new product introductions  including the quik combo adapter for the lifepak family of products  the lifepak c defibrillator monitor pacemaker  and the lifepak monitor 
the increase in international sales was primarily attributable to the company s investment in a dedicated european sales force focused exclusively on selling its products 
gross profit increased to million during from million for as a percentage of sales  gross profit improved to from in the improvement in gross profit was primarily attributable to improved efficiencies due to higher manufacturing volumes  lower material costs  and a million write up of the company s inventories on july  that was charged to cost of goods sold during research and development expense increased to million during  from million during increased expenditures reflected the company s continued development of new products  including a first responder external defibrillator product lifepak aed and the lifepak defibrillator  which was introduced into the market in sg a expenses decreased million or to million during  from million during and  as a percentage of sales  decreased to during from during the decrease was primarily attributable to a million reduction in depreciation expense related to the write down of fixed assets in conjunction with the acquisition on july  during  corporate expense allocations and management consulting fees increased million as a result of a million nonrecurring consulting fee payable to bain capital  inc under a management advisory agreement  which was terminated on december  charges during reflected a million corporate expense allocation from lilly and a million consulting fee paid to bain capital  inc there were no restructuring charges or credits during restructuring credits of million during reflected a million credit from the reversal of a charge taken during for planned downsizing associated with the company s temporary suspension of manufacturing operations  partially offset by a million charge taken during to record the cost of certain product upgrades 
other expenses increased million to million during  primarily attributable to a million increase in interest expense as a result of interest costs on the company s long term debt for the entire year versus the period july  to december  as discussed in liquidity and capital resources  the company refinanced its existing indebtedness during in connection with its initial public offering 
the company incurred a nonrecurring charge of million  net of tax  related to the writeoff of loan fees associated with this refinanced debt 
quarterly results the company s results of operations may fluctuate from quarter to quarter 
various factors may affect results of operations  including variations in timing of product orders  changes in product mix  timing of new product introductions  changes in distribution channels  actions of competitors and budgetary practices of the company s customers 
liquidity and capital resources since july   the company has financed its operations primarily through funds provided from operations and bank borrowings  as well as the receipt of approximately million from lilly in connection with purchase price adjustments 
prior to july   the financing requirements of the company were funded by lilly through intercompany transfers 
net cash used by operating activities for the period july  through december  totaled approximately million 
for the year ended december   the company generated approximately million in cash from operating activities  primarily as a result of the receipt of million from lilly  which was partially offset by decreases in income taxes payable and accrued liabilities and increases in receivables and inventories 
for the year ended december   the company used million in cash from operations 
during the period from july  to december  and for the years ended december  and  the company made capital expenditures of approximately million  million and million  respectively 
during and the majority of these capital expenditures were for manufacturing molds  computer equipment and maintenance equipment 
during the majority of the capital expenditures related to the purchase and implementation of the company s new computer business system 
the company currently has no capital commitments outside the ordinary course of business 
the company s principal working capital requirements are for financing accounts receivable and inventories 
at december   the company had working capital of million  including approximately million of trade accounts and other receivables and million of inventories 
in connection with the company s initial public offering in december  the company refinanced its existing indebtedness under its existing credit agreement and entered into the amended and restated credit agreement 
the amended and restated credit agreement provides for a revolving credit facility in an amount not to exceed million 
the revolving credit facility bears interest  at the company s option  at either i the lender s base rate the higher of such lender s prime rate or the federal funds rate plus  or ii libor plus 
such rates are subject to increase in the event that the company does not meet certain leverage and interest coverage ratios 
at december   the average interest rate on amounts outstanding under the credit facility were at various rates ranging from to 
the company s current indebtedness is secured by substantially all of the company s domestic assets and outstanding stock and contains representations  warranties  affirmative and negative covenants  and events of default customarily found in credit arrangements of this type 
at december   the company had borrowing availability under the credit facility of approximately million available for future borrowings after consideration of outstanding letters of credit of million  and was in compliance with all related loan covenants 
during and  the company issued subordinated promissory notes to lilly related to certain assets purchased 
the first notes  totaling million bear interest at libor plus per annum at december  and mature on january  an additional note payable dated october  totaling million bears interest at libor plus per annum at december  and matures november  at december   the company had an aggregate indebtedness of approximately million to lilly under such notes 
the company believes that  based upon current levels of operations and anticipated growth  funds generated from operations together with other available sources of liquidity  including borrowings under the existing credit facility  will be sufficient over the next twelve months for the company to make anticipated capital expenditures and fund working capital requirements 
one of the company s strategies is to evaluate and make strategic acquisitions of and or alliances with companies with complementary product lines 
future acquisitions may be financed by issuance of additional common stock  borrowings  or excess cash flow 
approximately of the company s net revenues during were from international customers and the company expects that sales to international customers will continue to represent a material portion of its net sales 
certain of the company s international receivables are denominated in foreign currency  and exchange rate fluctuations impact the carrying value of these receivables 
the company has elected to hedge certain assets denominated in foreign currency with the purchase of forward contracts 
historically  fluctuations in foreign currency exchange rates have not had a material effect on the company s results of operations and together  with certain hedging activities  the company does not expect such fluctuations to be material in the foreseeable future 
effect of inflation inflation generally affects the company by increasing the interest expense of floating rate indebtedness and by increasing the cost of labor  equipment and raw materials 
the company does not believe that inflation has had any material effect on the company s business over the past three years 

